HLB Co., Ltd.
028300
Rank in Stocks
#3914
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Share Price
$31.27
Market Cap
$4.16B
Change (1 day)
6.78%
Change (1 year)
1.26%
Country
KR
Trade HLB Co., Ltd. (028300)
Category
Healthcare
Stock price history for HLB Co., Ltd. (028300)
Highest end of day price: $29.89 on 2026-10-01
Lowest end of day price: $1.36 on 2008-12-01
Lowest end of day price: $1.36 on 2008-12-01
Stock price history of HLB Co., Ltd. from 2008 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 0.63% |
| 2025 | -33.96% |
| 2024 | 57.41% |
| 2023 | 40.26% |
| 2022 | -17.38% |
| 2021 | -30.97% |
| 2020 | 8.36% |
| 2019 | 23.72% |
| 2018 | 110.61% |
| 2017 | 199.59% |
| 2016 | -34.89% |
| 2015 | 161.99% |
| 2014 | 189.01% |
| 2013 | -5.55% |
| 2012 | 30.30% |
| 2011 | 0.39% |
| 2010 | -50.22% |
| 2009 | 13.14% |
| 2008 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $535.55 | 25.59% |
US
|
|
| $187.49 | 598.30% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $876.18 | 7.62% |
NL
|
